- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2021
- 266 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- June 2023
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2021
- 120 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 160 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2022
- 242 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- March 2024
- 103 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Molecular Biology Enzymes market is a subset of the larger Enzymes market, which is composed of enzymes used in molecular biology research and development. These enzymes are used to modify, amplify, and analyze DNA and RNA molecules, as well as to study gene expression and protein structure. Molecular biology enzymes are used in a variety of applications, including PCR, cloning, sequencing, and gene expression analysis.
The Molecular Biology Enzymes market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Thermo Fisher Scientific, Promega Corporation, New England Biolabs, Takara Bio, Agilent Technologies, Merck KGaA, and Bio-Rad Laboratories. Show Less Read more
